Effective: October 1, 1976
Latest Legislation: House Bill 912 - 111th General Assembly
(A) A retail seller of dangerous drugs shall disclose price information regarding dangerous drugs to any person requesting such information.
(B) Pursuant to division (A) of this section, a retail seller of dangerous drugs shall disclose price information in the following ways:
(1) By means of verbal disclosure on the premises of the retail seller to all persons requesting such information;
(2) By means of telephone to any person having a valid prescription, who identifies himself and requests such information.
(C) Price disclosure shall not be required for those schedule II controlled substances where lives or property could be endangered by such disclosure.